You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Development of a novel highly effective influenza vaccine

    SBC: FLUGEN INC            Topic: NIAID

    DESCRIPTION provided by applicant Seasonal influenza flu virus an NIAID category C priority pathogen causes widespread infection resulting in at least million cases of severe illness and deaths worldwide Young children and elderly or immunocompromised individuals are typically at greater risk of severe illness or death from influenza Newly emerging strains can result ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Development of Peptide Antibiotic Nucleic Acids

    SBC: NUBAD LLC            Topic: NIAID

    DESCRIPTION provided by applicant One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and progression to develop novel therapeutic strategies for diseases such as increasing menace of bacterial infections Targeting specific RNA such as rRNA which are involved in proliferation and survival ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. Science Take-Out Kits for Environmental Health Education

    SBC: Science Take-Out, LLC            Topic: NIEHS

    DESCRIPTION provided by applicant Nearly percent of death and disease worldwide is linked to environmental factors WHO therefore it is critical that the general public has basic understanding of how the environment affects their health and how they might protect themselves against environmental exposures Unfortunately environmental health content is typically covered on a very ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  4. Development and in vitro validation of therapy for mucopolysaccharidosis III

    SBC: Phoenix Nest Inc.            Topic: 105

    DESCRIPTION provided by applicant Sanfilippo disease mucopolysaccharidosis type III MPS III is a devastating neurodegenerative lysosomal storage disorder of childhood for which there is no cure or effective treatment available The fundamental cause of MPS III is an inherited mutation in one of the enzymes required to catabolize heparan sulfate HS a glycosaminoglycan which plays importa ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  5. Development of an Antigen Capture Assay for Babesia microti

    SBC: BIOPEPTIDES CORP            Topic: NIAID

    DESCRIPTION provided by applicant Babesia microti the primary etiologic agent of human babesiosis is a tick borne eukaryotic apicomplexan pathogen that is an increasing threat to the US public health Although B microti is primarily a tick borne pathogen it can be transmitted by transfusion of infected blood Despite the well recognized threat there is no FDA licensed test to screen donor ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Live-attenuated ETEC Anti-Diarrhea Vaccine Construction via Synthetic Biology

    SBC: Codagenix Inc.            Topic: NIAID

    DESCRIPTION provided by applicant The development of vaccine to combat Enterotoxigenic E coli ETEC is vital given the pathogenandapos s global impact on million individuals annually however an entirely new non conventional approach is needed Field studies have suggested that inert antigen based vaccines to combat ETEC have andquot essentially no efficacyandquot Therefore a vaccin ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Inflatable Wing Morphing Aircraft Aeroservoelastic Control and Design Demonstration

    SBC: Intelligent Automation, Inc.            Topic: T401

    The role of UASs in the DoD has been continuously growing and is expected to show much higher growth rates in operations in the near future. A pressing need for such platforms is the need to be able to satisfy multiple mission objectives, without "compromising" on efficiency. This need is further exacerbated by increasing fuel prices, that dictates higher aerodynamic efficiencies across the comple ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  8. ACE Booster

    SBC: GLOYER-TAYLOR LABORATORIES INC            Topic: T102

    GTL has been developing three transformational technologies that have the capability to disrupt the traditional launch vehicle paradigm. BHL composite cryotank technology provides a four times improvement over large Al-Li tanks, offering a 6 percentage point improvement in stage PMF. Superior Stability Engine is an innovative liquid rocket engine configured to maximize combustion stability margi ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  9. Acousto-Optic Tunable Filter-Based Polarimetric Spectral Sensor With Progressive Algorithm For Material Analysis and Mapping

    SBC: BRIMROSE TECHNOLOGY CORP            Topic: T801

    The prevalence of off earth landing missions both proposed and undertaken has been steadily increasing. With the proposal of missions, not only to Mars, but also to comets, asteroids and outer planet moons, the ruggedness and robustness of equipment must meet the challenges of ever harsher environments. As a part of these missions, researchers wish to analyze the materials which make up the surfac ...

    STTR Phase I 2014 National Aeronautics and Space Administration
  10. High Performance Nanolauncher

    SBC: Orbital Technologies Corporation            Topic: T101

    The proposed Low Cost Nanolauncher (LCN) is an upper stage using a new, inexpensive propulsion system. The Phase I program will combine several technologies with a simple design strategy to produce a flight-weight propulsion system that is easy to fabricate and operate. Self pressurizing propellants will minimize complexity of the propulsion system and vortex cold-wall technology will be used to ...

    STTR Phase I 2014 National Aeronautics and Space Administration
US Flag An Official Website of the United States Government